Itch in dermatomyositis: the role of increased skin interleukin‐31 HJ Kim, M Zeidi, D Bonciani, SM Pena, J Tiao, S Sahu, VP Werth British Journal of Dermatology 179 (3), 669-678, 2018 | 81 | 2018 |
Cannabinoid reduces inflammatory cytokines tumor necrosis factor alpha and type I interferons in dermatomyositis in vitro ES Robinson, P Alves, MM Bashir, M Zeidi, R Feng, VP Werth The Journal of investigative dermatology 137 (11), 2445, 2017 | 44 | 2017 |
Hepatitis B viral DNA among HBs antigen negative healthy blood donors M Vaezjalali, S Rashidpour, H Rezaee, B Hajibeigi, M Zeidi, L Gachkar, ... Hepatitis monthly 13 (3), 2013 | 39 | 2013 |
Increased myeloid dendritic cells and TNF-α expression predicts poor response to hydroxychloroquine in cutaneous lupus erythematosus M Zeidi, HJ Kim, VP Werth Journal of Investigative Dermatology 139 (2), 324-332, 2019 | 37 | 2019 |
Selective immunoglobulin A deficiency in Iranian blood donors: prevalence, laboratory and clinical findings S Shiva, P Zahra, A Asghar, PA Akbar, S Azam, F Maryam, A Zohreh, ... Iranian Journal of Allergy, Asthma and Immunology, 157-162, 2008 | 36 | 2008 |
Quinacrine suppresses tumor necrosis factor-α and IFN-α in dermatomyositis and cutaneous lupus erythematosus P Alves, MM Bashir, M Wysocka, M Zeidi, R Feng, VP Werth Journal of Investigative Dermatology Symposium Proceedings 18 (2), S57-S63, 2017 | 29 | 2017 |
The effects of immunostimulatory herbal supplements on autoimmune skin diseases CE Bax, S Chakka, JSS Concha, M Zeidi, VP Werth Journal of the American Academy of Dermatology 84 (4), 1051-1058, 2021 | 26 | 2021 |
Safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in patients with dermatomyositis with refractory skin disease: a randomized clinical trial VP Werth, E Hejazi, SM Pena, J Haber, M Zeidi, N Reddy, J Okawa, ... Journal of Investigative Dermatology 142 (10), 2651-2659. e1, 2022 | 25 | 2022 |
The prevalence of Selective Immunoglobulin M Deficiency (SIgMD) in Iranian volunteer blood donors N Entezari, Z Adab, M Zeydi, S Saghafi, M Jamali, GA Kardar, Z Pourpak Human immunology 77 (1), 7-11, 2016 | 24 | 2016 |
Sebaceous induction in dermatofibroma: a common feature of dermatofibromas on the shoulder M Zeidi, JP North Journal of Cutaneous Pathology 42 (6), 400-405, 2015 | 19 | 2015 |
Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM S Maddukuri, J Patel, DA Diaz, KL Chen, M Wysocka, C Bax, Y Li, ... Arthritis research & therapy 24 (1), 12, 2022 | 18 | 2022 |
The study of total IgE reference range in healthy adults in Tehran, Iran RS Shoormasti, Z Pourpak, MR Eshraghian, MTH Ashtiani, M Jamali, ... Iranian Journal of Public Health 39 (3), 32, 2010 | 17 | 2010 |
Determination of lymphocyte subsets reference values in healthy Iranian men by a single platform flow cytometric method AA Alamooti, FA Ardalan, A Abdolahi, M Zeidi, F Firouzjaie Cytometry Part A 77 (9), 890-894, 2010 | 16 | 2010 |
Myeloid dendritic cells are major producers of IFN-β in dermatomyositis and may contribute to hydroxychloroquine refractoriness KL Chen, J Patel, M Zeidi, M Wysocka, MM Bashir, B Patel, S Maddukuri, ... Journal of Investigative Dermatology 141 (8), 1906-1914. e2, 2021 | 14 | 2021 |
Acute onset/flares of dermatomyositis following ingestion of IsaLean® herbal supplement: clinical and immunostimulatory findings M Zeidi, PB Chansky, VP Werth Journal of the American Academy of Dermatology 80 (3), 801-804, 2019 | 14 | 2019 |
Recent advances in pharmacological treatments of adult dermatomyositis KL Chen, M Zeidi, VP Werth Current Rheumatology Reports 21, 1-10, 2019 | 10 | 2019 |
Polymorphisms and serum level of mannose-binding lectin: An Iranian survey A Soltani, S RahmatiRad, Z Pourpak, Z Alizadeh, S Saghafi, B HajiBeigi, ... Iranian Journal of Allergy, Asthma and Immunology, 428-432, 2014 | 9 | 2014 |
Increased MxA protein expression and dendritic cells in spongiotic dermatitis differentiates dermatomyositis from eczema in a single center case-control study M Zeidi, KL Chen, B Patel, A Ravishankar, R Lim, VP Werth Journal of Cutaneous Pathology, 2020 | 8 | 2020 |
Fri0307 lenabasum, a cannabinoid type 2 receptor agonist, reduces cd4 cell populations and downregulates type 1 and 2 interferon activities in lesional dermatomyositis skin K Chen, M Zeidi, N Reddy, B White, V Werth Annals of the Rheumatic Diseases 78 (Suppl 2), 835-835, 2019 | 8 | 2019 |
Increased CD69+ CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials M Zeidi, KL Chen, J Patel, K Desai, HJ Kim, S Chakka, R Lim, VP Werth Lupus 31 (4), 472-481, 2022 | 4 | 2022 |